Derma Sciences Cmn (DSCI) 4.55 $DSCI Derma Sciences

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Derma Sciences Cmn (DSCI) 4.55 $DSCI

Derma Sciences Completes the Sale of Its First Aid Products Division
BusinessWire - Thu Sep 01, 3:05PM CDT
Derma Sciences, Inc. (NasdaqSCI), a tissue regeneration company focused on advanced wound and burn care, announces the completion of the sale of its First Aid Division (FAD) to Dukal Corporation for $12.4 million, including inventory. The proposed sale was first announced on July 27, 2016.
DSCI: 4.55 (-0.03)

Henry Schein Poised on Strategic Buyouts, Pricing Hurts
Zacks Equity Research - Zacks Investment Research - Thu Sep 01, 6:23AM CDT
On Sep 1, we issued an updated research report on Henry Schein, Inc. (HSIC).
DSCI: 4.55 (-0.03), ALGN: 93.84 (+0.91), HSIC: 164.10 (+1.33), MMSI: 24.14 (-0.29)

Others Overlooked Derma Sciences (DSCI), Should You Buy It Now?
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 7:50AM CDT
Derma Sciences (DSCI) is well positioned for a solid gain, but has been overlooked by investors lately
DSCI: 4.55 (-0.03)

LabCorp's Takeover of Sequenom Wins Antitrust Clearance
Zacks Equity Research - Zacks Investment Research - Thu Aug 25, 4:26PM CDT
LabCorp (LH) recently got the antitrust review clearance for its previously announced acquisition of Sequenom.
DSCI: 4.55 (-0.03), SQNM: 2.39 (-0.01), ALGN: 93.84 (+0.91), LH: 135.38 (+0.70)

Derma Sciences Receives Reimbursement Coding for New MEDIHONEY(R) Hydrogel Dressings
BusinessWire - Thu Aug 25, 6:30AM CDT
Derma Sciences, Inc. (Nasdaq: DSCI), a tissue regeneration company focused on advanced wound and burn care, announces the launch of new, MEDIHONEY(R) Hydrogel Sheet Dressings and the receipt of Healthcare Common Procedural Coding System (HCPCS) codes awarded on August 19, 2016 by the Centers for Medicare and Medicaid Services (CMS).
DSCI: 4.55 (-0.03)

Derma Sciences' AMNIOEXCEL(R) Now Eligible for Reimbursement by Medicare Administrative Contractor NGS
BusinessWire - Wed Aug 24, 3:05PM CDT
Derma Sciences, Inc. (NasdaqSCI), a tissue regeneration company focused on advanced wound and burn care, announces that National Government Services (NGS), a Medicare Administrative Contractor (MAC) for Part B serving States primarily in the Northeast and Midwest, and National MAC for Jurisdiction 6, has retired its local coverage determination (LCD) for cellular or tissue-based products (CTPs) effective September 1, 2016. As a result, the Company's AMNIOEXCEL(R) Amniotic Allograft Membrane (AMNIOEXCEL(R)) will be considered for coverage with appropriate documentation of medical necessity as a second-line therapy following standard wound care treatment.
DSCI: 4.55 (-0.03)

LabCorp Q2 Results Strong, Sequenom Buyout Raises Hope
Zacks Equity Research - Zacks Investment Research - Fri Aug 19, 10:16AM CDT
On Aug 18, 2016, we issued an updated research report on LabCorp (LH), a leading independent clinical laboratory company.
DSCI: 4.55 (-0.03), ALGN: 93.84 (+0.91), LH: 135.38 (+0.70), ATRS: 1.43 (+0.03)

Derma Sciences Names Russell Olsen President of Advanced Wound Care
BusinessWire - Thu Aug 18, 6:30AM CDT
Derma Sciences, Inc. (NasdaqSCI), a tissue regeneration company focused on advanced wound and burn care, announces the appointment of Russell Olsen as President of Advanced Wound Care. Mr. Olsen is President and Chief Executive Officer of BioD, LLC, a regenerative medicine products company Derma Sciences acquired earlier this month.
DSCI: 4.55 (-0.03)

New Strong Buy Stocks for August 11th
Tirthankar Chakraborty - Zacks Investment Research - Thu Aug 11, 6:17AM CDT
New Strong Buy Stocks for August 11th
DSCI: 4.55 (-0.03), DISCK: 23.61 (-0.09), DGI: 24.59 (-0.66), BEAT: 18.44 (-0.75), CVCY: 15.80 (+0.07)

Derma Sciences Reports 2016 Second Quarter Financial Results
BusinessWire - Tue Aug 09, 6:30AM CDT
--2016 financial guidance revised to include recent transactions
DSCI: 4.55 (-0.03)

Derma Sciences to Hold Second Quarter Financial Results Conference Call on August 9th
BusinessWire - Wed Aug 03, 8:13AM CDT
Derma Sciences, Inc. (Nasdaq: DSCI), a tissue regeneration company focused on advanced wound and burn care, announced today that it will hold a conference call on August 9, 2016 to discuss the financial results for the second quarter of 2016. In addition, management will provide a business update and a discussion on recent and upcoming milestones.
DSCI: 4.55 (-0.03)

Derma Sciences to Acquire BioD, Solidify Its Leadership Position in Advanced Wound Care and Regenerative Products
BusinessWire - Thu Jul 28, 6:30AM CDT
--Will add 235 independent sales representatives and seven direct sales representatives with no call-point or customer overlap
DSCI: 4.55 (-0.03)

Why Derma Sciences (DSCI) Could Be Positioned for a Surge
Zacks Equity Research - Zacks Investment Research - Tue May 24, 7:35AM CDT
Derma Sciences (DSCI) has a decent short-term momentum and it is seeing solid activity on the earnings estimate revision front as well.
DSCI: 4.55 (-0.03)

Can The Uptrend Continue for Derma Sciences (DSCI)?
Zacks Equity Research - Zacks Investment Research - Thu May 19, 7:56AM CDT
Investors certainly have to be happy with Derma Sciences Inc (DSCI) and its short term performance
DSCI: 4.55 (-0.03)

Derma Sciences reports 1Q loss
Automated Insights - Wed May 11, 6:37AM CDT
PRINCETON, N.J. (AP) _ Derma Sciences Inc. (DSCI) on Wednesday reported a loss of $1.8 million in its first quarter.
DSCI: 4.55 (-0.03)

Derma Sciences Reports 2016 First Quarter Financial Results
BusinessWire - Wed May 11, 6:30AM CDT
--Conference call begins at 11:00 a.m. Eastern Time today
DSCI: 4.55 (-0.03)

Research and Markets -- European Advanced Wound Care Market Analysis - Trends, Technologies & Opportunities Report 2016-2021 - Key Vendors: Shire, Organogenesis, Derma Sciences
PR Newswire Europe - Fri May 06, 2:11PM CDT
DUBLIN, May 6, 2016 /PRNewswire/ --
DSCI: 4.55 (-0.03)

Derma Sciences to Hold First Quarter Financial Results Conference Call on May 11th
BusinessWire - Fri May 06, 1:31PM CDT
Derma Sciences, Inc. (NasdaqSCI), a tissue regeneration company focused on advanced wound and burn care, announced today that it will hold a conference call on May 11, 2016 to discuss the financial results for the first quarter of 2016. In addition, management will provide a business update and a discussion on recent and upcoming milestones.
DSCI: 4.55 (-0.03)

Derma Sciences Announces AMNIOEXCEL(R) Is Now Eligible for Reimbursement by Medicare Administrative Contractor CGS
BusinessWire - Wed Apr 27, 6:30AM CDT
Derma Sciences, Inc. (Nasdaq: DSCI), a tissue regeneration company focused on advanced wound and burn care, announces that CGS Administrators, LLC (CGS), a Medicare Administrative Contractor (MAC) for Parts A and B serving Kentucky and Ohio, has updated its local coverage determination (LCD) for cellular or tissue-based products (CTPs) of the lower extremity. As a result, the Company's AMNIOEXCEL(R) Amniotic Allograft Membrane (AMNIOEXCEL(R)) will be considered for reimbursement coverage with appropriate documentation of medical necessity for the treatment of chronic wounds of the lower extremity, including both diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs). Coverage is effective as of April 1, 2016. CGS is the sixth MAC to issue local coverage determinations for AMNIOEXCEL(R).
DSCI: 4.55 (-0.03)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Drowsy Driving Forum Spurs United Call for Safety Action

Updated Category News Views 40

A Fresh Coalition Against a Familiar Foe On a brisk late October day, the National Sleep Foundation (NSF) pulled together a motley crew of road safety veterans, vehicle makers, crash sniffers, and sleep legends at the National Press Club. This wasn't just another talkfest. With an estimated 61% of U.S. adults reportedly driving while half-asleep, something finally shook...

Continue Reading
tZERO Gains CFTC Approval, Paves Derivatives Path

Updated Category News Views 54

Breaking into New Territory: tZERO's CFTC Triumph tZERO just scored a touchdown in the financial arena with its newly minted approval from the Commodity Futures Trading Commission. This green light allows them to dive into derivatives trading and clearing, a colossal leap for their Infrastructure-as-a-Service model. You could almost feel the corporate chest-thumping as...

Continue Reading
Class Action Looms Over The Chemours Company

Updated Category News Views 83

Chemours Under Fire: What’s Happening? Here we are, in the thick of a legal storm surrounding The Chemours Company. A class-action lawsuit is underway, and it’s painting the company in a rather unflattering light. Now, if you snagged some of that NYSE:CC action between February 20, 2026, and August 4, 2026, there's a chance you’re caught in the crossfire. Per the...

Continue Reading
Global Case Studies in Poverty Reduction Spotlighted

Updated Category News Views 41

A Fresh Spotlight on Poverty Reduction Efforts Amid the clamor of social and economic challenges, 126 stellar case studies of poverty reduction just took center stage at a seminar in Beijing. These admired initiatives emerged from the seventh global solicitation, chosen from a pile of 890 entries submitted by do-gooders and organizations spanning 31 countries. If you've...

Continue Reading
LA Auto Show Partners with PetSet: A Charitable Drive

Updated Category News Views 61

A Unique Partnership Between Cars and Compassion Los Angeles is no stranger to the vibrant blend of culture and cars. This year, the Los Angeles Auto Show decided to steer things to a new lane of compassion by teaming up with PetSet. Now, if you're scratching your head wondering how the automobile world rides in tandem with animal welfare, grab a seat. The 'Road to Home...

Continue Reading
Data Centers: More Power-Hungry Than Thirsty

Updated Category News Views 49

Data Centers: Not Quite the Water Guzzlers We Feared Hold onto your hats, because the latest intel on data centers is changing the game, or at least forcing a closer look at what seems like a done deal. The big reveal? It's not the water, folks—it’s the juice. While everyone frets about water, electricity is the silent giant you’ve got to wrangle. Water vs....

Continue Reading
Regal Intel Pursues Uncharted Territory in Rare Disease Research

Updated Category News Views 54

New insights don't just appear out of thin air, and in the world of rare diseases, they’re often stuck behind data that’s never quite been tackled the right way. Here comes Regal Intel, a nonprofit making waves by diving into the deep end with two fresh seed grants. These folks are hell-bent on making sense of skin-deep and gut-wrenching issues that science hasn't...

Continue Reading
Animal Rescue Corps Executes Operation Cage Breaker

Updated Category News Views 30

ARC Springs Into Action in Rural Florida You ever think about those days where you feel like you're running against the current? That sums up the recent ordeal in Branford, Florida, where Animal Rescue Corps (ARC), a nonprofit, rolled up their sleeves for a major task under Operation Cage Breaker. This wasn’t some run-of-the-mill animal shelter duty. We’re talking a...

Continue Reading
Wyalusing Valley, Wysox Centers Change Ownership

Updated Category News Views 93

A New Chapter for Pennsylvania's Childcare Gems In the often unpredictable world of childcare services, a shift is happening in Pennsylvania that has John and Robyn Lacy stepping back after two decades of dedicated service. The Wyalusing Valley Children's Center and Wysox Children's Center have found a new home in the hands of a private investor, signifying a significant...

Continue Reading
HelloNation Spotlights Michigan Manufacturers' Achievements

Updated Category News Views 51

A Night of Recognition and Innovation Awaits Alright, folks, here's a story brewed from Michigan's manufacturing heartland. As the state gears up for the annual 2026 Manufacturing Excellence Awards, there's more being served up in Plymouth than just a fancy dinner and applause. CGI Digital and their posse at HelloNation are stepping into the fray, not just to clap...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Women in Insurance: Spotlight on Sarah Scott

Updated Category News Views 169

Recognizing Leadership in the Insurance Industry CorVel Corporation is thrilled to announce that Sarah Scott, the Executive Vice President of Product and Corporate Services, has been included in Business Insurance's esteemed "Women to Watch" list for the upcoming year. This recognition, which celebrates its 20th anniversary, honors women who have made significant strides...

Continue Reading
Celebrating Tomorrow's Insurance Leaders: 2024 Finalists Revealed

Updated Category News Views 86

Introduction to the 2024 RGA Leaders of Tomorrow Finalists The International Insurance Society (IIS) recently announced the exciting finalists for the 2024 RGA Leaders of Tomorrow award. This prestigious accolade recognizes a select group of individuals worldwide who exhibit exceptional potential in leadership within the insurance and risk management sectors. Highlighting...

Continue Reading
European Patent Awarded to FibroBiologics for Tumor Targeting Innovation

Updated Category News Views 174

FibroBiologics Secures European Patent for Innovative Technology FibroBiologics, Inc., a clinical-stage biotechnology company renowned for its groundbreaking efforts in therapeutics, has recently been awarded a significant patent by the European Patent Office. This achievement pertains to a novel method utilizing modified fibroblasts to deliver tumor-inhibiting agents...

Continue Reading
AC Circuit Breaker Market Set for $6.58B Boom by 2031

Updated Category News Views 27

Shifting Perceptions of a Critical Technology The world isn't running out of surprises, let me tell you. Once dismissed in the engineering world as unremarkable, AC circuit breakers have shocked back into the limelight, upping their game in today's green-powered rush. With a rush of interest driven by a modernizing grid, these babies are riding a 6.3% CAGR wave, expected...

Continue Reading
Investors Alert: Alto Neuroscience Faces Legal Challenges

Updated Category News Views 146

Alto Neuroscience Legal Investigation Overview Alto Neuroscience, Inc. is currently under scrutiny due to potential securities law violations, drawing the attention of investors and legal entities. As a result of recent developments, investors are being urged to assess their options in light of ongoing litigation against the company. If you purchased Alto stock, you may...

Continue Reading